0000902664-11-001618.txt : 20111114 0000902664-11-001618.hdr.sgml : 20111111 20111114161934 ACCESSION NUMBER: 0000902664-11-001618 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110930 FILED AS OF DATE: 20111114 DATE AS OF CHANGE: 20111114 EFFECTIVENESS DATE: 20111114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Noble Partners, L. P. CENTRAL INDEX KEY: 0001350882 IRS NUMBER: 043116388 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-11605 FILM NUMBER: 111202821 BUSINESS ADDRESS: STREET 1: 265 FRANKLIN STREET STREET 2: 21ST FLOOR CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 617-646-6500 MAIL ADDRESS: STREET 1: 265 FRANKLIN STREET STREET 2: 21ST FLOOR CITY: BOSTON STATE: MA ZIP: 02110 13F-HR 1 p11-1814form13fhr.txt NOBLE PARTNERS, L.P. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 13F Form 13F COVER PAGE Report for the Calendar Year or Quarter Ended: September 30, 2011 --------------------------- Check here if Amendment []; Amendment Number: ------- This Amendment (Check only one.): [ ] is a restatement. [ ] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: NOBLE PARTNERS, L.P. -------------------------------------------- Address: 265 FRANKLIN ST., 21ST FLOOR -------------------------------------------- BOSTON, MA 02110 -------------------------------------------- Form 13F File Number: 28-11605 ----------------- The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form. Persons Signing this Report on Behalf of Reporting Manager: Name: GEORGE L. NOBLE ------------------------------------------------- Title: PRESIDENT, PEAK ASSET MGT., INC., GENERAL PARTNER, NOBLE PARTNERS, L.P. ------------------------------------------------- Phone: 617-646-6500 ------------------------------------------------- Signature, Place, and Date of Signing: /s/ GEORGE L. NOBLE BOSTON, MA 11/14/2011 --------------------------------- --------------------------------- --------- [Signature] [City, State] [Date] Report Type (Check only one): [X] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) [ ] 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) [ ] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) List of Other Managers Reporting for this Manager: Form 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 0 Form 13F Information Table Entry Total: 21 Form 13F Information Table Value Total: $ 23,142 -------------- (In Thousands) Provide a numbered list of the name(s) and 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report. NONE
FORM 13F INFORMATION TABLE COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8 ---------------------------- -------------- --------- -------- ----------------- ---------- -------- ------------------- VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGERS SOLE SHARED NONE ---------------------------- -------------- --------- -------- -------- --- ---- ---------- -------- ------- ------ ---- ACADIA PHARMACEUTICALS INC COM 004225108 22 20,000 SH SOLE 20,000 0 0 AKORN INC COM 009728106 1,014 130,000 SH SOLE 130,000 0 0 ALLERGAN INC COM 018490102 906 11,000 SH SOLE 11,000 0 0 AMARIN CORP PLC SPONS ADR NEW 023111206 276 30,000 SH SOLE 30,000 0 0 ARIAD PHARMACEUTICALS INC COM 04033A100 352 40,000 SH SOLE 40,000 0 0 BANRO CORP COM 066800103 257 65,500 SH SOLE 65,500 0 0 BIOSANTE PHARMACEUTICALS INC COM NEW 09065V203 296 130,000 SH SOLE 130,000 0 0 CARDIOME PHARMA CORP COM NEW 14159U202 316 96,100 SH SOLE 96,100 0 0 CUBIST PHARMACEUTICALS INC COM 229678107 883 25,000 SH SOLE 25,000 0 0 DENDREON CORP COM 24823Q107 180 20,000 SH SOLE 20,000 0 0 ELAN PLC ADR 284131208 421 40,000 SH SOLE 40,000 0 0 GOLAR LNG PARTNERS LP COM UNIT LPI Y2745C102 1,918 75,000 SH SOLE 75,000 0 0 HUMAN GENOME SCIENCES INC COM 444903108 381 30,000 SH SOLE 30,000 0 0 JAZZ PHARMACEUTICALS INC COM 472147107 291 7,000 SH SOLE 7,000 0 0 MEDICIS PHARMACEUTICAL CORP CL A NEW 584690309 547 15,000 SH SOLE 15,000 0 0 NORTHGATE MINERALS CORP COM 666416102 839 250,000 SH SOLE 250,000 0 0 PERRIGO CO COM 714290103 777 8,000 SH SOLE 8,000 0 0 SALIX PHARMACEUTICALS INC COM 795435106 740 25,000 SH SOLE 25,000 0 0 TESLA MTRS INC COM 88160R101 3,903 160,000 SH PUT SOLE 160,000 0 0 UNITED STATES NATL GAS FUND UNIT NEW 912318110 8,105 900,000 SH PUT SOLE 900,000 0 0 WELLPOINT INC COM 94973V107 718 11,000 SH SOLE 11,000 0 0